Antylia Scientific™, a global company focused on peristaltic and associated fluid path products that provide bioprocessing solutions, and with a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare, and environmental markets, has announced the creation of  60 roles in Co Westmeath with the establishment of its Masterflex® Bioprocessing facility in the National Science Park, Mullingar.

Minister for Trade Promotion, Digital and Company Regulation Robert Troy TD said: “I am delighted that Antylia has chosen to establish its new facility in Mullingar, creating some 60 new highly skilled jobs. 

'Global hub for leading biopharmaceutical companies'

"It is a significant announcement for Mullingar and a strong endorsement of the midlands as an excellent location for businesses to establish and thrive. Our highly skilled workforce is just one reason why Ireland is recognised as a global hub for leading biopharmaceutical companies like Antylia Scientific.

"Our mission in government is to get people back to work and rebuild the economy and a priority focus for me in the Department of Enterprise is to promote balanced regional development across the country.”

The new Masterflex Bioprocessing facility will be used to design and manufacture Masterflex® peristaltic technologies that are used in mission-critical pharmaceutical and bioprocessing workflows for the development and production of vaccines and therapeutics. The facility will also include a large warehouse space to store components and the finished products.

This investment by Antylia Scientific and the IDA in the new Masterflex Bioprocessing facility will expand access to these critical fluid path products and provide customers with shorter lead times, simplified sourcing and validation and increased supply for these critical fluid path products.

'Tremendous opportunity'

"We are grateful to the Irish government through IDA Ireland for this tremendous opportunity,” said Brian Barnett, president of Masterflex Bioprocessing. “We are thrilled to open our first facility in Ireland to produce and house Masterflex® peristaltic technologies and associated fluid path products.

"These products are in great demand globally. The addition of this site to our Masterflex Bioprocessing family of global sites providing mission critical products and services will help the overall Biopharma industry. It is a win-win situation that will positively benefit our customers, our Masterflex brand, and the Mullingar workforce and economy.”

The jobs being created at the new Masterflex Bioprocessing facility in Mullingar are in the areas of process and medical device engineering, manufacturing as well as logistics and supply chain. 

CEO of IDA Ireland Martin Shanahan said: “Today’s announcement by Antylia Scientific is a very positive one for the Midlands and is a strong endorsement in the region’s talented and highly skilled Biopharma and MedTech workforce. Antylia Scientific’s significant investment in its Mullingar facility based at the National Science Park demonstrates the company’s commitment to the Midlands region.  I wish Antylia every success with this investment.” 

To explore opportunities to join the Antylia Scientific team in Mullingar, visit Antylia Scientific on LinkedIn or to learn more about Antylia Scientific and Masterflex please visit  www.antylia.com and www.masterflex.com. 

This project is supported by the government through IDA Ireland.